An automated and multiplexed method for high throughput peptide immunoaffinity enrichment and multiple reaction monitoring mass spectrometry-based quantification of protein biomarkers.
about
Mass spectrometry for translational proteomics: progress and clinical implicationsProteomics investigations of HDL: challenges and promiseOmics-Based Strategies in Precision Medicine: Toward a Paradigm Shift in Inborn Errors of Metabolism InvestigationsSolid-phase extraction strategies to surmount body fluid sample complexity in high-throughput mass spectrometry-based proteomicsDesign, implementation and multisite evaluation of a system suitability protocol for the quantitative assessment of instrument performance in liquid chromatography-multiple reaction monitoring-MS (LC-MRM-MS)ProteinSeq: high-performance proteomic analyses by proximity ligation and next generation sequencingIdentification and quantification of a new family of peptide endocannabinoids (Pepcans) showing negative allosteric modulation at CB1 receptors.Statistical design for biospecimen cohort size in proteomics-based biomarker discovery and verification studiesProteomics, morphoproteomics, saliva and breast cancer: an emerging approach to guide the delivery of individualised thermal therapy, thermochemotherapy and monitor therapy response.Targeting peptide termini, a novel immunoaffinity approach to reduce complexity in mass spectrometric protein identification.Automated screening of monoclonal antibodies for SISCAPA assays using a magnetic bead processor and liquid chromatography-selected reaction monitoring-mass spectrometry.MALDI immunoscreening (MiSCREEN): a method for selection of anti-peptide monoclonal antibodies for use in immunoproteomics.Moxifloxacin Concentration and Proteomic Analysis of Aqueous Humor in Human Uveitis Associated with Oral Moxifloxacin TherapyProteomic analysis and discovery using affinity proteomics and mass spectrometry.Mass spectrometric immunoassay revisitedMass spectrometry-based protein assays for in vitro diagnostic testing.Combining ultracentrifugation and peptide termini group-specific immunoprecipitation for multiplex plasma protein analysis.Mass-spectrometry-based clinical proteomics--a review and prospective.Mass spectrometry-based proteomics: existing capabilities and future directionsAntibody-independent targeted quantification of TMPRSS2-ERG fusion protein products in prostate cancer.Sialic acid-focused quantitative mouse serum glycoproteomics by multiple reaction monitoring assay.Ensembles of protein termini and specific proteolytic signatures as candidate biomarkers of disease.OARSI Clinical Trials Recommendations: Soluble biomarker assessments in clinical trials in osteoarthritis.Targeted proteomic quantitation of the absolute expression and turnover of cystic fibrosis transmembrane conductance regulator in the apical plasma membrane.The sweet and sour of serological glycoprotein tumor biomarker quantification.Analytical challenges translating mass spectrometry-based phosphoproteomics from discovery to clinical applications.MICROFLUIDIC DEVICES FOR LABEL-FREE AND NON-INSTRUMENTED QUANTITATION OF UNAMPLIFIED NUCLEIC ACIDS BY FLOW DISTANCE MEASUREMENT.Evaluation of large scale quantitative proteomic assay development using peptide affinity-based mass spectrometry.Targeted quantitative mass spectrometric immunoassay for human protein variants.Simultaneous quantification of apolipoprotein A-I and apolipoprotein B by liquid-chromatography-multiple- reaction-monitoring mass spectrometryMethods for peptide and protein quantitation by liquid chromatography-multiple reaction monitoring mass spectrometry.Anti-peptide monoclonal antibodies generated for immuno-multiple reaction monitoring-mass spectrometry assays have a high probability of supporting Western blot and ELISA.Peptide immunoaffinity enrichment coupled with mass spectrometry for peptide and protein quantification.Quantification of proteins using peptide immunoaffinity enrichment coupled with mass spectrometryA targeted proteomics-based pipeline for verification of biomarkers in plasmaTargeted mass spectrometric approach for biomarker discovery and validation with nonglycosylated tryptic peptides from N-linked glycoproteins in human plasmaPeptide Immunoaffinity Enrichment and Targeted Mass Spectrometry Enables Multiplex, Quantitative Pharmacodynamic Studies of Phospho-Signaling.Analytical Performance of ELISA Assays in Urine: One More Bottleneck towards Biomarker Validation and Clinical Implementation.Enhancing bottom-up and top-down proteomic measurements with ion mobility separationsAdvancing the sensitivity of selected reaction monitoring-based targeted quantitative proteomics.
P2860
Q26995497-072A135F-40C4-4D6D-985A-83B6AAC7EA94Q27000995-39042B7A-0112-42B1-835F-775E54A1D669Q28068009-19EA8C20-BAE5-4E27-A3AA-CC7423068191Q28650185-5349BD3B-4289-4A27-9FFA-5B0B2EFA3260Q28681060-2274424B-42CC-4A7B-8C87-3A48E3A45304Q28744412-1550304B-C269-44F9-85C6-50ADC5C048CBQ30561814-4975F061-E2A2-488A-B308-F2BDB1749FA4Q33688759-8A27896C-11E8-4279-9983-D05698E68E9FQ33694698-7AA29D94-B189-4A3B-9BC1-51F0CE22D87FQ33723801-FEEF0C08-3F6D-4AF5-A277-EB90A56D152EQ33731947-E73B2187-3BE5-40BA-A58C-895EC2031392Q33747200-41186A30-1E06-4B6A-929D-A214A74464B4Q33826630-A7169432-58A5-4BAB-A854-15E1773FC6EAQ33932582-4E57529D-B650-420D-A4FC-28B0B8D0F856Q34033095-1AAE2CE9-611C-4206-A4A5-44DECCF2E407Q34216869-4AA4148F-F56A-4AFF-A5D8-BDA0B373DAD1Q34242987-2BF72C2B-DCED-48EA-98ED-FFABD1AFE03CQ34252113-01E7E1BF-90CD-4547-B57C-E25BC565E161Q34267972-134817FA-4895-4161-8092-FC9E17DAF593Q34283031-23F682AA-0019-4C40-8F62-A9DBBCFBB642Q34320706-29C3991D-24E1-4ABD-AAC5-99B4485A3558Q34402330-DB66669D-7B76-4962-AB61-12F33730899FQ34475498-00C305A9-D334-466B-AAC1-54E0314A5C04Q34488617-08471943-7D88-43E8-854B-F9F49535284CQ34580285-5B9094EB-C2F3-44B9-A0D9-9084E90F8159Q34604043-F820532D-0516-46DD-912C-76DBA2EF2D0FQ34723111-0580876F-FBDC-4203-8E4D-23AAB00A6780Q34751690-70FEB95B-4EEC-4F4D-B4C7-A21A8D7C9705Q34825391-9286D0C4-CB1E-4C36-8678-09BD3CA1DCFAQ35012598-5296CEEA-93AD-44B4-AC34-70EFF22B8132Q35026899-33C8A5EC-34F1-4C2C-A1CD-8DBCA402B964Q35148573-46175665-CE74-4B65-8EF3-7D8358B4128FQ35264312-007E0470-CCF6-4B67-89DD-73A5E08C82EDQ35396713-7FDE7732-289C-4BB3-B014-DF3811116416Q35596338-B8CB4F1A-0CE2-4232-9372-FB0D268D29DEQ35610651-2FB529B4-C523-404D-A63B-C2C43CCEC7DFQ35926217-F32ED83A-5115-455A-8BFD-DC7625408520Q35926986-9F56B34F-6E25-45EC-ABEE-52205A4BCA59Q35945797-E5ED5FF9-D9C4-4C21-93ED-626DEDFB5037Q36031629-AABC26E6-E3B6-46D7-BC79-FFF120F8D06B
P2860
An automated and multiplexed method for high throughput peptide immunoaffinity enrichment and multiple reaction monitoring mass spectrometry-based quantification of protein biomarkers.
description
2009 nî lūn-bûn
@nan
2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
An automated and multiplexed m ...... ication of protein biomarkers.
@ast
An automated and multiplexed m ...... ication of protein biomarkers.
@en
type
label
An automated and multiplexed m ...... ication of protein biomarkers.
@ast
An automated and multiplexed m ...... ication of protein biomarkers.
@en
prefLabel
An automated and multiplexed m ...... ication of protein biomarkers.
@ast
An automated and multiplexed m ...... ication of protein biomarkers.
@en
P2093
P2860
P1476
An automated and multiplexed m ...... ication of protein biomarkers.
@en
P2093
Amanda G Paulovich
Jeffrey R Whiteaker
Leigh Anderson
P2860
P304
P356
10.1074/MCP.M900254-MCP200
P577
2009-10-20T00:00:00Z